Patent ID: 11873339
Assignee: PIERRE FABRE MEDICAMENT
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 21:
22. The method of claim 21, wherein
the enzyme is selected from the group consisting of horseradish peroxidase, alkaline phosphatase, beta-galactosidase, and acetylcholinesterase,
the fluorescent compound is selected from the group consisting of umbelliferone, fluorescein, fluorescein isothiocynate, rhodamine, dichlorotriazinylamine fluorescein, dansyl chloride and phycoerythrin,
the bioluminescent compound is selected from the group consisting of luciferase, luciferin, and aequorin,
the chemiluminescent compound is luminol, or
the radioisotope is selected from the group consisting of 131I, 125I, 123I, 121I, 14C, 35S, 3H, 115In, 113In, 112In, 111In, 99Tc, 201Ti, 68Ga, 67Ga, 103Pd, 99Mo, 133Xe, 18F, 153Sm, 177Lu, 159Gd, 149Pm, 140La, 175Yb, 166Ho, 90Y, 47Sc, 186Re, 188Re, 142Pr, 105Rh, 97Ru, 68Ge, 57Co, 65Zn, 85Sr, 32P, 153Gd, 169Yb, 51Cr, 54Mn, 75Se, 113Sn, and 117Sn.